Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review
Visceral leishmaniasis, also known as kala-azar is one of the most commonly neglected tropical diseases affecting a large number of rural and resource-limited people in South Asia, Africa, and South America. Paromomycin, an aminoglycoside drug, is frequently used for the treatment of visceral leishm...
Main Authors: | Pashupati Pokharel, Rakesh Ghimire, Pratik Lamichhane |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/8629039 |
Similar Items
-
Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
by: Wiwanitkit V
Published: (2012-06-01) -
Hearing loss associated with paromomycin treatment in a patient with visceral leishmaniasis
by: Rocio Asensi-Diez, et al.
Published: (2017-05-01) -
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
by: Ridwanur Rahman, et al.
Published: (2017-05-01) -
Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
by: Prabhat K. Sinha, et al.
Published: (2011-01-01) -
Effectiveness of Paromomycin on Cutaneous Leishmaniasis in Iran: A Systematic Review and Meta-Analysis
by: Rahmatollah Moradzadeh, et al.
Published: (2019-05-01)